HeartSciences Inc. (HSCSW) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: फ़रवरी 18, 2025
HeartSciences Inc. Stock Price Chart and Technical Analysis
Loading chart data...
Loading HeartSciences Inc. interactive price chart and technical analysis...
HeartSciences Inc. (HSCSW) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
HeartSciences Inc. (Stock Symbol: HSCSW)
is a leading company in the Industrial Applications and Services sector
, specifically operating within the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $0 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for HeartSciences Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
HeartSciences Inc. strategically competes in the highly dynamic
Orthopedic, Prosthetic & Surgical Appliances & Supplies marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
HeartSciences Inc. (HSCSW) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for HeartSciences Inc. stock analysis.
Loading fundamental data...
Loading HeartSciences Inc. comprehensive fundamental analysis and insider trading data...
Deep dive into HeartSciences Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if HeartSciences Inc. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For HeartSciences Inc.:
P/B Ratio0.01x
Market Cap$0M
EPS$-2.27
Book Value/Share$4.24
Revenue/Share$0.02
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently HeartSciences Inc. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For HeartSciences Inc.:
Operating Margin-12787.7%
Net Margin-12558.9%
Understanding Financial Health Metrics
What these metrics mean: These ratios assess HeartSciences Inc.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For HeartSciences Inc.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal HeartSciences Inc.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For HeartSciences Inc.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively HeartSciences Inc. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For HeartSciences Inc.:
Understanding Financial Statement Data
What these metrics mean: Key figures from HeartSciences Inc.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For HeartSciences Inc.:
Income Statement ($ Millions)
Operating Income$-1M
Net Income$-2M
R&D Expense$1M
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding1M
Growth Metrics (YoY)
EPS Growth-5536.6%
Latest HeartSciences Inc. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting HeartSciences Inc. (HSCSW) stock price and investment outlook.
HeartSciences reports progress in AI-powered ECG technology, with developments in their MyoVista platform and upcoming FDA submissions. Quiver AI Summary HeartSciences Inc., a medical technology ...
HeartSciences Inc., an AI-driven medical technology company, reported its financial results for the fiscal year ending April 30, 2025, and highlighted its strategic advancements in transforming ...
Southlake, TX, June 03, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”) powered medical ...
Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on ...
Southlake, TX, March 10, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company ...
Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (HSCS) (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical ...
Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. (HSCS) d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial ...
Heart Test Laboratories Inc d/b/a HeartSciences HSCS has been issued a notice of patent allowance from the European Patent Office. To date, HeartSciences has been granted or allowed 41 patents ...
HeartSciences' first product candidate for FDA clearance, the MyoVista® wav ECG™, or the MyoVista®, is a resting 12-lead ECG that is also designed to provide diagnostic information related to ...
Detailed price information for Heartsciences Inc (HSCS-Q) from The Globe and Mail including charting and trades.
HeartSciences Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector
Comparative analysis of HeartSciences Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - HeartSciences Inc. Stock Forecast
How accurate are HeartSciences Inc. stock predictions?
Our AI model demonstrates 85% historical accuracy for HSCSW predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence HeartSciences Inc. stock price forecasts?
Based on our AI analysis, HeartSciences Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are HeartSciences Inc. forecasts updated?
HeartSciences Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced HeartSciences Inc. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for HeartSciences Inc. stock.
